The JAK2V617F mutation may yield polycythemia vera (PV), essential thrombocythemia, or primary myelofibrosis (MF), the three diseases that constitute classic BCR-ABL–negative MPN. The gene discussed is ABL1; the disease is acquired polycythemia vera.